HPV73 a nonvaccine type causes cervical cancer.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 09 01 2019
revised: 14 03 2019
accepted: 25 03 2019
pubmed: 10 4 2019
medline: 7 2 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

HPV73 is classified as possibly oncogenic. It is neither routinely evaluated in HPV screening, nor covered by any of the prophylactic vaccines. We sought to investigate the carcinogenic characteristics of HPV73. Molecular studies were performed on eight cervix cancer biopsy specimens containing HPV73 from a cross-sectional cancer cohort of 590 women referred to the National Cancer Institute in Rio de Janeiro, Brazil. Transcriptional activity of HPV73 was evaluated by detection of spliced transcripts of E6/E6* and E1^E4 in cDNA created from RNA isolated from fresh tissue. Disruption of viral E1 and E2 genes in the tumor DNA was assessed by overlapping PCR amplification. Evaluation of viral integration was performed using a customized capture panel and next-generation sequencing, and an in-house bioinformatic pipeline. HPV73 E6/E6* transcripts were found in 7/7 specimens with available RNA, and three also had HPV73 E1^E4 transcripts. Disruption of E1 and E2 genes was observed in 4/8 specimens. Integration of HPV73 sequences into the cancer cell genomes was identified in all cervix cancer tissues. These results provide evidence that HPV73 is an oncogenic virus that can cause invasive cervix cancer. With current molecular screening and HPV vaccination, not all cervix cancers will be prevented.

Identifiants

pubmed: 30963559
doi: 10.1002/ijc.32315
pmc: PMC6785350
mid: NIHMS1024274
doi:

Substances chimiques

DNA, Neoplasm 0
Oncogene Proteins, Viral 0
RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

731-738

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI124414
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA013330
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA078527
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA078527
Pays : United States

Informations de copyright

© 2019 UICC.

Références

Med Microbiol Immunol. 1987;176(5):245-56
pubmed: 2821369
Clin Sci (Lond). 2006 May;110(5):525-41
pubmed: 16597322
J Am Acad Dermatol. 2011 May;64(5):981-5
pubmed: 20584560
Hum Pathol. 2014 Feb;45(2):303-9
pubmed: 24355194
Nature. 2013 Aug 8;500(7461):207-11
pubmed: 23925245
PLoS One. 2010 Sep 17;5(9):null
pubmed: 20862247
Virology. 2018 Mar;516:86-101
pubmed: 29331867
Nucleic Acids Res. 2003 Jan 1;31(1):51-4
pubmed: 12519945
Nat Biotechnol. 2015 Mar;33(3):306-12
pubmed: 25485619
Virology. 2005 Jun 20;337(1):76-84
pubmed: 15914222
N Engl J Med. 1998 Feb 12;338(7):423-8
pubmed: 9459645
Oncotarget. 2016 Feb 2;7(5):5852-64
pubmed: 26735580
Papillomavirus Res. 2017 Dec;4:85-89
pubmed: 29179875
Int J Cancer. 2011 Feb 15;128(4):927-35
pubmed: 20473886
J Pathol. 2014 Dec;234(4):441-51
pubmed: 25043390
Virology. 1987 Aug;159(2):389-98
pubmed: 3039733
Genome Res. 2014 Feb;24(2):185-99
pubmed: 24201445
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3373-3377
pubmed: 29286606
Nucleic Acids Res. 2013 Jan;41(Database issue):D571-8
pubmed: 23093593
Virology. 2016 Jun;493:202-8
pubmed: 27060563
Am J Surg Pathol. 2011 Jul;35(7):998-1006
pubmed: 21681144
J Clin Microbiol. 2012 Jan;50(1):61-5
pubmed: 22075592
Int J Gynecol Cancer. 2001 May-Jun;11(3):198-204
pubmed: 11437925
J Infect Dis. 1998 Jul;178(1):252-5
pubmed: 9652449
J Clin Pathol. 2004 Jan;57(1):68-72
pubmed: 14693839
Dermatol Surg. 2008 Mar;34(3):407-13
pubmed: 18248476
J Environ Public Health. 2017;2017:1645074
pubmed: 28512474
Nat Rev Dis Primers. 2016 Dec 01;2:16086
pubmed: 27905473
Int J Cancer. 2016 Jun 15;138(12):2932-9
pubmed: 26851121

Auteurs

Sergio M Amaro-Filho (SM)

Genetics Program, National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Ana Gradissimo (A)

Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY.

Mykhaylo Usyk (M)

Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY.

Fabio C B Moreira (FCB)

Pathology Division (DIPAT), National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Liz M de Almeida (LM)

Department of Epidemiology, National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Miguel A M Moreira (MAM)

Genetics Program, National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Robert D Burk (RD)

Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY.
Department of Epidemiology and Population Health, Microbiology and Immunology, and Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH